Dipeptide nitrile inhibitors of cathepsin K

被引:22
作者
Altmann, E [1 ]
Aichholz, R [1 ]
Betschart, C [1 ]
Buhl, T [1 ]
Green, J [1 ]
Lattmann, R [1 ]
Missbach, M [1 ]
机构
[1] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland
关键词
D O I
10.1016/j.bmcl.2006.01.104
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of dipeptidyl nitrites as inhibitors of cathepsin K have been explored starting from lead structure 1 (Cbz-Leu-NH-CH2-CN IC50 = 39 nM). Attachment of non-natural amino acid side chains in P1 and modification of the P3 subunit led to inhibitors with higher potency and improved pharmacokinetic properties. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2549 / 2554
页数:6
相关论文
共 10 条
[1]  
Baron R., 2003, Primer on the metabolic bone diseases and disorders of mineral metabolism, P1
[2]  
Burr D.B., 2003, PRIMER METABOLIC BON, P58
[3]  
CAMPAGNA F, 1977, TETRAHEDRON LETT, V21, P1813
[4]   The collagenolytic activity of cathepsin K is unique among mammalian proteinases [J].
Garnero, P ;
Borel, O ;
Byrjalsen, I ;
Ferreras, M ;
Drake, FH ;
McQueney, MS ;
Foged, NT ;
Delmas, PD ;
Delaissé, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32347-32352
[5]   Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design [J].
Greenspan, PD ;
Clark, KL ;
Tommasi, RA ;
Cowen, SD ;
McQuire, LW ;
Farley, DL ;
van Duzer, JH ;
Goldberg, RL ;
Zhou, HH ;
Du, ZM ;
Fitt, JJ ;
Coppa, DE ;
Fang, Z ;
Macchia, W ;
Zhu, LJ ;
Capparelli, MP ;
Goldstein, R ;
Wigg, AM ;
Doughty, JR ;
Bohacek, RS ;
Knap, AK .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (26) :4524-4534
[6]   MOLECULAR-CLONING OF HUMAN CDNA FOR CATHEPSIN-K - NOVEL CYSTEINE PROTEINASE PREDOMINANTLY EXPRESSED IN BONE [J].
INAOKA, T ;
BILBE, G ;
ISHIBASHI, O ;
TEZUKA, K ;
KUMEGAWA, M ;
KOKUBO, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (01) :89-96
[7]  
KRICHELDORF HR, 1972, LIEBIGS ANN CHEM, V763, P17
[8]   REVERSIBLE COVALENT INHIBITION OF PAPAIN BY A PEPTIDE NITRILE - C-13 NMR EVIDENCE FOR A THIOIMIDATE ESTER ADDUCT [J].
MOON, JB ;
COLEMAN, RS ;
HANZLIK, RP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1986, 108 (06) :1350-1351
[9]   Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K [J].
Palmer, JT ;
Bryant, C ;
Wang, DX ;
Davis, DE ;
Setti, EL ;
Rydzewski, RM ;
Venkatraman, S ;
Tian, ZQ ;
Burrill, LC ;
Mendonca, RV ;
Springman, E ;
McCarter, J ;
Chung, T ;
Cheung, H ;
Janc, JW ;
McGrath, M ;
Somoza, JR ;
Enriquez, P ;
Yu, ZW ;
Strickley, RM ;
Liu, L ;
Venuti, MC ;
Percival, MD ;
Falgueyret, JP ;
Prasit, P ;
Oballa, R ;
Riendeau, D ;
Young, RN ;
Wesolowski, G ;
Rodan, SB ;
Johnson, C ;
Kimmel, DB ;
Rodan, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) :7520-7534
[10]   Design and synthesis of dipeptide nitriles as reversible and potent cathepsin S inhibitors [J].
Ward, YD ;
Thomson, DS ;
Frye, LL ;
Cywin, CL ;
Morwick, T ;
Emmanuel, MJ ;
Zindell, R ;
McNeil, D ;
Bekkali, Y ;
Giradot, M ;
Hrapchak, M ;
De Turi, M ;
Crane, K ;
White, D ;
Pav, S ;
Wang, Y ;
Hao, MH ;
Grygon, CA ;
Labadia, ME ;
Freeman, DM ;
Davidson, W ;
Hopkins, JL ;
Brown, ML ;
Spero, DM .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (25) :5471-5482